Polarization of the α6β4 integrin in ovarian carcinomas

C. Bottini, S. Miotti, S. Fiorucci, P. Facheris, S. Menard, M. I. Colnaghi

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

By immunizing a BALB/c mouse with a human ovary-carcinoma cell line (IGROV1), grown intraperitoneally in nude mice, a monoclonal antibody (MAb), designated MAR6, was produced and characterized. Immunofluorescence on the immunizing cell line showed a specific labelling by MAR6 at the cell-to-cell contact points. In addition, MAR6 was found to immunoprecipitate the α6β4 integrin complex. Competition tests with MAbs anti-α6, anti-β4, anti-β1 sub-units demonstrated that the recognized sub-units is α6. Indirect immunofluorescence on various cell lines gave MAR6 as positive only on α6-positive lines (IGROV1, OVCAR3, SW626, SKOV3, ME4405, Calu3, N592, MDA468, A431 and HT29). Moreover, on IGROV1 and OVCAR3 ovary-carcinoma cells, which normally grow either adhering to the culture flask or forming clumps in suspension in the medium, MAR6 selectively stained the connection points between the cells in clumps, where, in the same position, the presence of the β4 sub-unit, laminin and fibronectin was detected. On the contrary, the β1 sub-unit was distributed over the whole cell membrane. The same pattern of labelling by these MAbs was observed in 2 cases of ovarian-carcinoma cells present in ascitic fluids obtained from patients. Immunoperoxidase tests performed oin cryosections of various normal tissues showed specific reactivity of MAR6 on basal or basolateral membranes of epithelial cells. On cryosections of ovarian tumors, MAR6 reactivity correlated with the degree of tumor differentiation. Indeed, in benign and well-differentiated tumors, a strong basal or basolateral labelling only of cells surrounding the neoplastic nodules was found. On the contrary, on undifferentiated tumors the inner part of the tumor nodules was also progressively labelled, whereas the staining on the border was weak and discontinuous as a result of the α6 sub-unit dispersion on the tumor cell surface.

Original languageEnglish
Pages (from-to)261-267
Number of pages7
JournalInternational Journal of Cancer
Volume54
Issue number2
DOIs
Publication statusPublished - 1993

Fingerprint

Integrins
Carcinoma
Neoplasms
Cell Line
Ovary
Ascitic Fluid
Laminin
Indirect Fluorescent Antibody Technique
Fibronectins
Nude Mice
Fluorescent Antibody Technique
Suspensions
Epithelial Cells
Monoclonal Antibodies
Cell Membrane
Staining and Labeling
Membranes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Bottini, C., Miotti, S., Fiorucci, S., Facheris, P., Menard, S., & Colnaghi, M. I. (1993). Polarization of the α6β4 integrin in ovarian carcinomas. International Journal of Cancer, 54(2), 261-267. https://doi.org/10.1002/ijc.2910540217

Polarization of the α6β4 integrin in ovarian carcinomas. / Bottini, C.; Miotti, S.; Fiorucci, S.; Facheris, P.; Menard, S.; Colnaghi, M. I.

In: International Journal of Cancer, Vol. 54, No. 2, 1993, p. 261-267.

Research output: Contribution to journalArticle

Bottini, C, Miotti, S, Fiorucci, S, Facheris, P, Menard, S & Colnaghi, MI 1993, 'Polarization of the α6β4 integrin in ovarian carcinomas', International Journal of Cancer, vol. 54, no. 2, pp. 261-267. https://doi.org/10.1002/ijc.2910540217
Bottini C, Miotti S, Fiorucci S, Facheris P, Menard S, Colnaghi MI. Polarization of the α6β4 integrin in ovarian carcinomas. International Journal of Cancer. 1993;54(2):261-267. https://doi.org/10.1002/ijc.2910540217
Bottini, C. ; Miotti, S. ; Fiorucci, S. ; Facheris, P. ; Menard, S. ; Colnaghi, M. I. / Polarization of the α6β4 integrin in ovarian carcinomas. In: International Journal of Cancer. 1993 ; Vol. 54, No. 2. pp. 261-267.
@article{0a0553ce5e904c11a0d9a3b0684ce55e,
title = "Polarization of the α6β4 integrin in ovarian carcinomas",
abstract = "By immunizing a BALB/c mouse with a human ovary-carcinoma cell line (IGROV1), grown intraperitoneally in nude mice, a monoclonal antibody (MAb), designated MAR6, was produced and characterized. Immunofluorescence on the immunizing cell line showed a specific labelling by MAR6 at the cell-to-cell contact points. In addition, MAR6 was found to immunoprecipitate the α6β4 integrin complex. Competition tests with MAbs anti-α6, anti-β4, anti-β1 sub-units demonstrated that the recognized sub-units is α6. Indirect immunofluorescence on various cell lines gave MAR6 as positive only on α6-positive lines (IGROV1, OVCAR3, SW626, SKOV3, ME4405, Calu3, N592, MDA468, A431 and HT29). Moreover, on IGROV1 and OVCAR3 ovary-carcinoma cells, which normally grow either adhering to the culture flask or forming clumps in suspension in the medium, MAR6 selectively stained the connection points between the cells in clumps, where, in the same position, the presence of the β4 sub-unit, laminin and fibronectin was detected. On the contrary, the β1 sub-unit was distributed over the whole cell membrane. The same pattern of labelling by these MAbs was observed in 2 cases of ovarian-carcinoma cells present in ascitic fluids obtained from patients. Immunoperoxidase tests performed oin cryosections of various normal tissues showed specific reactivity of MAR6 on basal or basolateral membranes of epithelial cells. On cryosections of ovarian tumors, MAR6 reactivity correlated with the degree of tumor differentiation. Indeed, in benign and well-differentiated tumors, a strong basal or basolateral labelling only of cells surrounding the neoplastic nodules was found. On the contrary, on undifferentiated tumors the inner part of the tumor nodules was also progressively labelled, whereas the staining on the border was weak and discontinuous as a result of the α6 sub-unit dispersion on the tumor cell surface.",
author = "C. Bottini and S. Miotti and S. Fiorucci and P. Facheris and S. Menard and Colnaghi, {M. I.}",
year = "1993",
doi = "10.1002/ijc.2910540217",
language = "English",
volume = "54",
pages = "261--267",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Polarization of the α6β4 integrin in ovarian carcinomas

AU - Bottini, C.

AU - Miotti, S.

AU - Fiorucci, S.

AU - Facheris, P.

AU - Menard, S.

AU - Colnaghi, M. I.

PY - 1993

Y1 - 1993

N2 - By immunizing a BALB/c mouse with a human ovary-carcinoma cell line (IGROV1), grown intraperitoneally in nude mice, a monoclonal antibody (MAb), designated MAR6, was produced and characterized. Immunofluorescence on the immunizing cell line showed a specific labelling by MAR6 at the cell-to-cell contact points. In addition, MAR6 was found to immunoprecipitate the α6β4 integrin complex. Competition tests with MAbs anti-α6, anti-β4, anti-β1 sub-units demonstrated that the recognized sub-units is α6. Indirect immunofluorescence on various cell lines gave MAR6 as positive only on α6-positive lines (IGROV1, OVCAR3, SW626, SKOV3, ME4405, Calu3, N592, MDA468, A431 and HT29). Moreover, on IGROV1 and OVCAR3 ovary-carcinoma cells, which normally grow either adhering to the culture flask or forming clumps in suspension in the medium, MAR6 selectively stained the connection points between the cells in clumps, where, in the same position, the presence of the β4 sub-unit, laminin and fibronectin was detected. On the contrary, the β1 sub-unit was distributed over the whole cell membrane. The same pattern of labelling by these MAbs was observed in 2 cases of ovarian-carcinoma cells present in ascitic fluids obtained from patients. Immunoperoxidase tests performed oin cryosections of various normal tissues showed specific reactivity of MAR6 on basal or basolateral membranes of epithelial cells. On cryosections of ovarian tumors, MAR6 reactivity correlated with the degree of tumor differentiation. Indeed, in benign and well-differentiated tumors, a strong basal or basolateral labelling only of cells surrounding the neoplastic nodules was found. On the contrary, on undifferentiated tumors the inner part of the tumor nodules was also progressively labelled, whereas the staining on the border was weak and discontinuous as a result of the α6 sub-unit dispersion on the tumor cell surface.

AB - By immunizing a BALB/c mouse with a human ovary-carcinoma cell line (IGROV1), grown intraperitoneally in nude mice, a monoclonal antibody (MAb), designated MAR6, was produced and characterized. Immunofluorescence on the immunizing cell line showed a specific labelling by MAR6 at the cell-to-cell contact points. In addition, MAR6 was found to immunoprecipitate the α6β4 integrin complex. Competition tests with MAbs anti-α6, anti-β4, anti-β1 sub-units demonstrated that the recognized sub-units is α6. Indirect immunofluorescence on various cell lines gave MAR6 as positive only on α6-positive lines (IGROV1, OVCAR3, SW626, SKOV3, ME4405, Calu3, N592, MDA468, A431 and HT29). Moreover, on IGROV1 and OVCAR3 ovary-carcinoma cells, which normally grow either adhering to the culture flask or forming clumps in suspension in the medium, MAR6 selectively stained the connection points between the cells in clumps, where, in the same position, the presence of the β4 sub-unit, laminin and fibronectin was detected. On the contrary, the β1 sub-unit was distributed over the whole cell membrane. The same pattern of labelling by these MAbs was observed in 2 cases of ovarian-carcinoma cells present in ascitic fluids obtained from patients. Immunoperoxidase tests performed oin cryosections of various normal tissues showed specific reactivity of MAR6 on basal or basolateral membranes of epithelial cells. On cryosections of ovarian tumors, MAR6 reactivity correlated with the degree of tumor differentiation. Indeed, in benign and well-differentiated tumors, a strong basal or basolateral labelling only of cells surrounding the neoplastic nodules was found. On the contrary, on undifferentiated tumors the inner part of the tumor nodules was also progressively labelled, whereas the staining on the border was weak and discontinuous as a result of the α6 sub-unit dispersion on the tumor cell surface.

UR - http://www.scopus.com/inward/record.url?scp=0027167016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027167016&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910540217

DO - 10.1002/ijc.2910540217

M3 - Article

C2 - 8486429

AN - SCOPUS:0027167016

VL - 54

SP - 261

EP - 267

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -